ArticleDrugs & aging2021

Authors' Reply to Moura et al.: "Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk".

Suraj Rajasimhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.